Dosing in renal impairment

Core Principles - Why Kidneys Count

Renal impairment critically alters pharmacokinetics. The primary effect is ↓ drug clearance, leading to a prolonged half-life and ↑ risk of drug accumulation and toxicity.

• Total Clearance: Drug elimination is the sum of all clearance routes.
  • $Cl_{total} = Cl_{renal} + Cl_{hepatic} + Cl_{other}$
• Drug Dependence:
  • Renally Cleared: Aminoglycosides, lithium. Dose adjustment is critical.
  • Hepatically Cleared: Macrolides. Less affected by renal function.

⭐ High-Yield: Drugs with a narrow therapeutic index primarily cleared by the kidneys (e.g., digoxin, lithium, aminoglycosides) are most dangerous in renal impairment.

Renal Function Assessment - The Formula Frenzy

• Cockcroft-Gault Equation: The clinical standard for estimating creatinine clearance (CrCl) to guide drug dosing adjustments. It is less accurate in obesity, edema, or low muscle mass.

  • Formula: $CrCl (mL/min) = \frac{(140 - Age) \times Lean Body Weight (kg)}{72 \times Serum Creatinine (mg/dL)} (\times 0.85 \text{ for females})$

• MDRD & CKD-EPI Equations: Primarily used to estimate Glomerular Filtration Rate (eGFR) for staging Chronic Kidney Disease (CKD), not typically for drug dosing.

⭐ For many drugs, dosing recommendations are based on CrCl from Cockcroft-Gault, as this was the formula used in the original drug development studies.

Adjustment Strategies - Dose Down or Space Out?

When renal function declines, drug elimination slows. To maintain a therapeutic steady-state concentration and avoid toxicity, adjustments are necessary. The goal is to achieve the same Area Under the Curve (AUC) as in a patient with normal renal function.

• Two Primary Strategies:
  • Dose Reduction: ↓ maintenance dose, same interval.
  • Interval Extension: Same maintenance dose, ↑ interval.

• When to Use Which:

  • Dose Reduction: For time-dependent antimicrobials (e.g., β-lactams). This keeps drug levels consistently above the MIC.
  • Interval Extension: For concentration-dependent antimicrobials (e.g., aminoglycosides). This achieves a high peak (Cmax) for maximal killing.

• Loading Dose: Unchanged. It's based on Volume of Distribution (Vd), not clearance.

⭐ For aminoglycosides, extending the interval is preferred. It maximizes the concentration-dependent killing and post-antibiotic effect while allowing low trough levels, which reduces the risk of nephrotoxicity.

High-Risk Drugs - The Renal Hit List

⭐ Unlike unfractionated heparin, LMWH is primarily cleared by the kidneys, leading to unpredictable accumulation and ↑ bleeding risk in severe CKD.

High-Yield Points - ⚡ Biggest Takeaways

• Renal impairment primarily affects the excretion of water-soluble drugs, leading to ↑ drug accumulation and toxicity.
• Creatinine clearance (CrCl), estimated by the Cockcroft-Gault equation, is the standard for assessing renal function for dosing.
• Adjust dosing by either ↓ the dose or extending the interval between doses.
• Loading doses are typically unchanged as they depend on the volume of distribution (Vd), not clearance.
• Maintenance doses must be reduced.
• Drugs with narrow therapeutic windows (e.g., digoxin, aminoglycosides, lithium) require cautious dose adjustments and monitoring.